Though, if they did that to show to Fuji that a TO was not going to work and instead they should agree with Celularity to allow CYP to continue as an entity in it's own right producing therapies for both companies, would that not be in shareholder interests in the longer term?
W
CYP
Price at posting:
$1.28 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.